The Brazilian pharma market: Key information and what may change
Pharmaceutical Technology
DECEMBER 9, 2022
It is estimated that Brazil’s SUS currently spends around 10% of the country’s GDP on its healthcare, which before the election, was forecast to rise to 12.6% A recent report from GlobalData states that the Brazilian generics market grew by 9.67% year-on-year in 2021 to $5.2bn, accounting for around 29.4%
98 
Let's personalize your content